The second way that NR4A1 promotes lung cancer cell proliferation is by inhibiting p53 expression to induce Adenosine 5’-monophosphate (AMP)-activated protein kinase (AMPK)/mechanistic Target of Rapamycin Complex 1 (mTORC1) pathway activation (25). This evidence concerns the gene NR4A1 and lung carcinoma.